PACTR202301748714019尚未招募2 期
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial
niversity of Cape Town0 个研究点目标入组 200 人开始时间: 2023年1月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •1) HIV uninfected at birth
- •2) Delivered at term
- •3) No pregnancy or delivery complications including birth asphyxia, seizures, sepsis, birth weight
- •4) >2.4kgs, and no known contraindications to probiotic supplementation
排除标准
- •Mother: 1) Complications during pregnancy and delivery such as gestational diabetes, obesity (BMI> 35 prior to pregnancy), chorioamnionitis and eclampsia
- •2) Active TB or other infectious diseases
- •3) Administration of probiotics, prebiotics or immunoregulatory products
- •Infant: 1) Hypoxic injury/ seizures/ sepsis/ Intrauterine growth retardation
- •2) Administration of probiotics, prebiotics or immunoregulatory products
研究者
相似试验
已完成
不适用
Bifidobacterium Supplementation for Very Low Birth Weight InfantsPreterm InfantsNCT01375309Tokyo Women's Medical University246
已完成
不适用
Early Administration of Bifidobacterium to Very Low Birth Weight InfantsPreterm InfantsNCT01330095Tokyo Women's Medical University36
招募中
不适用
B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIVHivVaccine ReactionMicrobial ColonizationInfant DevelopmentNCT05923333University of Cape Town200
已完成
不适用
Effect of the addition of pre-biotics to infant formula on markers of immune development and atopy at 5 years of ageallergyinfections1000170810019815NL-OMON35946Danone Research156
进行中（未招募）
不适用
Infant Microbiota and Probiotic Intake StudyHealthyNCT02457338University of California, Davis120